This test is most useful if any of these apply to you.
Persistent bloating, gas, and diarrhea can have several causes. A glucose breath test can contribute to an investigation of small intestinal bacterial overgrowth, especially when your medical history makes it plausible. It's used clinically, but its accuracy is limited and its role in otherwise uncomplicated irritable bowel syndrome remains disputed.
This result summarizes the increase in breath hydrogen above its starting level during the first 90 minutes after a glucose drink. It is one part of the full breath test. The starting concentration, individual timed samples, and methane results provide information that this single number leaves out. Concentrations are reported in parts per million, abbreviated ppm.
Certain gut bacteria release hydrogen when they break down carbohydrates. Some of that gas crosses the intestinal wall into your blood, reaches your lungs, and leaves in your breath. Glucose is usually absorbed in the upper small intestine, so an early hydrogen rise can suggest that bacteria fermented it before absorption.
The timing provides an indirect clue to where fermentation occurred. It doesn't locate the bacteria. Glucose can sometimes reach the colon quickly enough to produce an early rise there, while absorption in the upper small intestine can prevent the drink from reaching overgrowth farther down. The size of the rise also depends on gas production, gas consumption by other microbes, and sample collection, so it isn't a direct count of bacteria or a validated measure of disease severity.
Small intestinal bacterial overgrowth (SIBO) involves excessive bacteria in the small intestine associated with digestive symptoms. It can cause bloating, gas, diarrhea, and, in more severe cases, poor nutrient absorption. Conditions that impair movement through the small intestine and some surgical changes to its anatomy can make overgrowth more likely.
The traditional reference test collects small-intestinal fluid during an endoscopy and cultures it in a laboratory. That approach is invasive and imperfect. Sampling can miss overgrowth outside the sampled area, contamination can occur, and culture methods don't capture every organism.
A pooled analysis found that glucose breath testing detected about 55 of every 100 culture-positive cases and was negative in about 83 of every 100 culture-negative cases. The corresponding estimates for lactulose breath testing were about 42 and 71. These studies used different doses, sampling schedules, and definitions of a positive result, so the pooled figures are not a precise validation of this particular 90-minute measurement.
A negative result can therefore miss SIBO. A positive result becomes more convincing when you have symptoms and a condition that predisposes you to overgrowth, but it still needs to be interpreted with the full curve and possible sources of error.
Irritable bowel syndrome (IBS) involves recurring abdominal pain with changes in bowel habits. Some studies find positive glucose breath tests more often in people with IBS than in healthy controls. One older study found positive results in about 31 in 100 adults with IBS, compared with 4 in 100 controls. It used an earlier glucose protocol and a different interpretation rule from the current 90-minute approach.
In a study of 116 adults with IBS, about 23 in 100 had a positive glucose hydrogen breath test. Among participants with positive carbohydrate breath tests, those with positive glucose tests were more likely to have severe IBS than those with lactose or fructose malabsorption. This association doesn't establish that bacterial overgrowth caused the symptoms.
Professional guidance reflects that uncertainty. The 2020 American College of Gastroenterology guideline conditionally supported breath testing in IBS, based on very low-quality evidence. A 2024 practice update endorsed by European and American neurogastroenterology societies argued against using breath testing to diagnose SIBO in IBS because diagnostic accuracy and the proposed causal link remain inadequate. IBS symptoms alone don't establish a bacterial cause.
Children's studies need similar care. In 161 children with recurring functional abdominal pain, about 14 in 100 met the study's definition of a positive glucose test. Most positive classifications came from high fasting hydrogen, and the study used different criteria. That percentage cannot be treated as the rate of an abnormal 90-minute hydrogen rise.
If the glucose drink moves through your small intestine unusually quickly, some can reach the colon before the early sampling window ends. Bacteria normally living there can then produce a rise that resembles small-intestinal fermentation.
A study of 139 people combined glucose breath testing with scans that tracked the drink. Nearly half of the positive tests reflected colon fermentation according to the scans. Among positive tests in people with previous upper digestive surgery, the proportion was about two thirds. The study counted rises in either hydrogen or methane using its own criteria, so those figures should not be applied directly to this hydrogen-only result or to everyone having a breath test.
Surgery can change both the risk of true overgrowth and the chance of a misleading breath result. The type of operation matters. A scan that tracks transit during breath testing can help investigate where fermentation occurred in selected cases, but breath timing alone cannot settle that question.
Gallbladder removal has also been associated with positive glucose breath tests. In a Korean study, nearly half of 62 people with digestive symptoms after gallbladder removal tested positive. The study included 237 people across three groups and counted fasting gas abnormalities as well as changes after glucose. It didn't show that surgery caused a larger 90-minute hydrogen rise or determine how many results reflected rapid transit.
Cirrhosis is advanced scarring of the liver. In an older study of people with cirrhosis, glucose breath hydrogen testing agreed poorly with small-intestinal fluid culture. Depending on the interpretation criteria, it detected between 27% and 52% of culture-positive cases and correctly classified between 36% and 80% of culture-negative cases. These results show substantial uncertainty in that population; they don't establish the performance of this exact 90-minute value.
Some microbes consume hydrogen to make methane. These organisms belong to a group called archaea. Their activity can reduce the hydrogen that reaches your breath, which is one reason a low hydrogen rise can be misleading.
Methane is interpreted separately and is associated with constipation. A methane-positive pattern can support intestinal methanogen overgrowth (IMO), which can involve the small intestine or colon. Measuring methane adds information, but it doesn't turn a flat hydrogen curve into proof of SIBO or eliminate every cause of a false-negative result.
Repeated results reflect both biology and testing conditions. A study of 40 healthy adults found only moderate repeatability for glucose-stimulated hydrogen measurements, with better repeatability for methane. Some healthy volunteers also received positive classifications. The study considered either gas and used a broader testing window, so it doesn't directly establish repeatability of the hydrogen rise by 90 minutes.
A smaller rise on a later test can accompany a response to treatment, but it doesn't by itself establish recovery. Symptoms, nutritional problems, and the underlying reason for suspected overgrowth remain part of the assessment.
Evidence-backed interventions that affect your H₂ Rise by 90 minutes - Glucose level
H₂ Rise by 90 minutes - Glucose is best interpreted alongside these tests.
H₂ Rise by 90 minutes - Glucose is included in these pre-built panels.
Look for a gas pattern that can help explain bloating, diarrhea, constipation, and gas.